Cargando…
Parkinson’s Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees
BACKGROUND: Sporadic Parkinson’s disease (PD) patients have lower α-galactosidase A (α-GAL A) enzymatic activity and Fabry disease (FD) patients potentially carry an increased risk of PD. OBJECTIVE: Determination of PD prevalence in FD and clinical, biochemical and vascular neuroimaging description...
Autores principales: | Gago, Miguel Fernandes, Azevedo, Olga, Guimarães, Andreia, Teresa Vide, Ana, Lamas, Nuno J., Oliveira, Tiago Gil, Gaspar, Paulo, Bicho, Estela, Miltenberger-Miltenyi, Gabriel, Ferreira, Joaquim, Sousa, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029331/ https://www.ncbi.nlm.nih.gov/pubmed/31594250 http://dx.doi.org/10.3233/JPD-191704 |
Ejemplares similares
-
Fabry Disease Therapy: State-of-the-Art and Current Challenges
por: Azevedo, Olga, et al.
Publicado: (2020) -
Fabry Disease and the Heart: A Comprehensive Review
por: Azevedo, Olga, et al.
Publicado: (2021) -
Natural history of the late-onset phenotype of Fabry disease due to the p.F113L mutation
por: Azevedo, Olga, et al.
Publicado: (2020) -
Different protocols for analyzing behavior and adaptability in obstacle crossing in Parkinson’s disease
por: Mollaei, Nafiseh, et al.
Publicado: (2017) -
Rare Association of two Genetic Causes of Sudden Death in a Young
Survivor
por: Brito, Dulce, et al.
Publicado: (2017)